Bayer extends winning streak, with $2B Roundup verdict reduced to $86.7M
The more than $2 billion verdict against Bayer and its Roundup weed killer has been reduced to $86.7 million by a judge in Oakland, California. A jury in the case in May had awarded more than $2 billion in damages to a husband and wife who contended their use of Roundup caused their non-Hodgkin's lymphoma. Bayer called the ruling Thursday “a step in the right direction,” but said it plans to appeal because “we continue to believe t hat the verdict and damage awards are not supported by the… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - July 26, 2019 Category: Pharmaceuticals Authors: Greg Edwards Source Type: news

Pediatric Lymphoma Joins Family of BRCA2 Cancers Pediatric Lymphoma Joins Family of BRCA2 Cancers
Researchers call for genetic testing of all survivors of pediatric non-Hodgkin lymphoma after data revealed BRCA2 is implicated in the childhood disease.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - July 26, 2019 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

The BRCA2 gene also raises the risk of childhood non-Hodgkin's lymphoma, study finds 
A new study from St Jude Children's Research Hospital has found that about two percent of childhood survivors of non-Hodgkin's lymphoma had inherited mutation of the BRCA2 gene. (Source: the Mail online | Health)
Source: the Mail online | Health - July 25, 2019 Category: Consumer Health News Source Type: news

Breast Implants Linked to Rare Cancer Are Recalled Worldwide
Under pressure from the Food and Drug Administration, Allergan will stop selling textured implants. 33 deaths have been tied to this type of implant. (Source: NYT)
Source: NYT - July 24, 2019 Category: American Health Authors: Denise Grady Tags: Allergan Inc Cancer Breasts Implants Non-Hodgkin ' s Lymphoma Recalls and Bans of Products Food and Drug Administration your-feed-healthcare Source Type: news

Researchers unveil experimental compound to block therapeutic target in blood cancer
(UNC Lineberger Comprehensive Cancer Center) UNC Lineberger Comprehensive Cancer Center researchers have discovered a hyperactive cell signal that contributes to tumor growth in primary effusion lymphoma, an aggressive type of non-Hodgkin lymphoma caused by infection with the Kaposi's sarcoma-associated herpesvirus (human herpesvirus-8). They also reported in the PNAS paper that they've developed an experimental therapeutic, UNC3810A, to block the signal and slow tumor growth. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - July 22, 2019 Category: Cancer & Oncology Source Type: news

Notes from the Field: Conjunctivitis Caused by Toxigenic Corynebacterium ulcerans --- Missouri, 2018
On December 12, 2018, an immunocompromised man with non-Hodgkin's lymphoma, aged 73 years, was evaluated by an ophthalmologist for left eyelid redness, swelling, and eye discharge and received a diagnosis of ligneous (pseudomembranous) conjunctivitis. (Source: CDC Morbidity and Mortality Weekly Report)
Source: CDC Morbidity and Mortality Weekly Report - July 11, 2019 Category: American Health Tags: Conjunctivitis MMWR Morbidity & Mortality Weekly Report Pseudomonas Source Type: news

Cancer Victim Sues Monsanto, Says It Misrepresented Safety Of Roundup, Glyphosate
SAN FRANCISCO - A California man on June 21 sued Monsanto Co. in California federal court, contending that he has developed non-Hodgkin lymphoma (NHL) as a result of exposure to glyphosate, the active ingredient in the herbicide Roundup, which he alleges Monsanto has misrepresented as a safe product (Saul Cohen v. Monsanto Company, No. 19-3632, N.D. Calif.). (Source: LexisNexis® Mealey's™ Emerging Toxic Torts Legal News)
Source: LexisNexis® Mealey's™ Emerging Toxic Torts Legal News - July 10, 2019 Category: Medical Law Source Type: news

Class-action lawsuit filed in Calgary over breast implants and cancer
Allergan Inc. is facing legal action after a type of breast implants it sold was linked by Health Canada to a higher risk of a rare form of non-Hodgkin's lymphoma. (Source: CBC | Health)
Source: CBC | Health - June 21, 2019 Category: Consumer Health News Tags: News/Canada/Calgary Source Type: news

A bone marrow transplant saved boy, 10, from cancer - then nearly killed him
Danny Feltwell Jr, 10, suffered from non-Hodgkin lymphoma. A bone marrow transplant treated his relapse, but then he got graft-versus-host disease. An experimental treatment has him back to pitching. (Source: the Mail online | Health)
Source: the Mail online | Health - June 12, 2019 Category: Consumer Health News Source Type: news

FDA approves first chemoimmunotherapy regimen for patients with relapsed or refractory diffuse large B-cell lymphoma
Today, the U.S. Food and Drug Administration granted accelerated approval to Polivy (polatuzumab vedotin-piiq), in combination with the chemotherapy bendamustine and a rituximab product (a combination known as "BR"), to treat adult patients with diffuse large B-cell lymphoma (DLBCL) that has progressed or returned after at least two prior therapies. Polivy is a novel antibody-drug conjugate, and DLBCL is the most common type of non-Hodgkin lymphoma. (Source: World Pharma News)
Source: World Pharma News - June 10, 2019 Category: Pharmaceuticals Tags: Featured FDA Regulatory Affairs Source Type: news

Monsanto Roundup lawsuits spread to Australia
A gardener in Australia has sued Bayer over its Monsanto Roundup weedkiller, the first such lawsuit against the German pharmaceutical giant in that country. Michael Ogalirolo, 54, a self-employed gardener from Melbourne, said he was diagnosed with non-Hodgkin lymphoma, a type of leukemia, after using Monsanto’s Roundup for more than 20 years, Reuters reported. “We have great sympathy for any individual with cancer, but the extensive body of scie nce on glyphosate-based herbicides over four… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - June 7, 2019 Category: Pharmaceuticals Authors: Greg Edwards Source Type: news

Cancer-stricken mother, 26, survives after doctors warned her organs would soon start shutting down
Varrie Dunlop, 26, of Ringwood, Hampshire, was diagnosed with stage four non-Hodgkin's lymphoma last November after doctors initially dismissed her fatigue as a viral infection. (Source: the Mail online | Health)
Source: the Mail online | Health - June 7, 2019 Category: Consumer Health News Source Type: news

Pennsylvania Couple: Monsanto Liable For Cancer From Glyphosate Exposure
PHILADELPHIA - A husband and wife on May 30 sued Monsanto Co. in federal court in Pennsylvania, contending that the wife developed non-Hodgkin lymphoma (NHL) as a result of exposure to the company's herbicide Roundup, which the plaintiffs say was marketed despite the company's knowledge that it causes cancer (Ruth Yobs, et al. v. Monsanto Co., No. 19-2362, E.D. Pa.). (Source: LexisNexis® Mealey's™ Emerging Toxic Torts Legal News)
Source: LexisNexis® Mealey's™ Emerging Toxic Torts Legal News - June 5, 2019 Category: Medical Law Source Type: news

Walking speed predicts clinical outcomes in older adults with blood cancers
(American Society of Hematology) How slow -- or fast -- older individuals with blood cancers are able to walk four meters (about 13 feet) holds critical information about their overall health and strongly predicts survival and unplanned hospital visits regardless of age, cancer or treatment type, or other factors, according to a new study published today inBlood. The association was strongest in those with non-Hodgkin lymphoma. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 5, 2019 Category: Cancer & Oncology Source Type: news

Lenalidomide + Rituximab Beneficial in Relapsed/Refractory Non-Hodgkin Lymphoma
The MAGNIFY phase IIIb trial looked at the efficacy and safety of lenalidomide combined with rituximab in  relapsed/refractory indolent non-Hodgkin lymphoma. (Source: CancerNetwork)
Source: CancerNetwork - June 3, 2019 Category: Cancer & Oncology Authors: Jim Kling Source Type: news

Bayer receives U.S. FDA breakthrough therapy designation for copanlisib for the treatment of marginal zone lymphoma
Bayer announced today that the U.S. Food and Drug Administration (FDA) granted Breakthrough Therapy Designation for copanlisib (Aliqopa™) for the treatment of adult patients with relapsed marginal zone lymphoma (MZL) who have received at least two prior therapies. MZL is an indolent form of non-Hodgkin's Lymphoma (iNHL) and accounts for about 10% of all non-Hodgkin's Lymphoma in the U.S. (Source: World Pharma News)
Source: World Pharma News - May 29, 2019 Category: Pharmaceuticals Tags: Featured Bayer Business and Industry Source Type: news

California Couple Get $2 Billion in Roundup Suit
The couple said they used Roundup on their property for more than three decades and were diagnosed with the same type of cancer, non-Hodgkin lymphoma, four years apart. (Source: WebMD Health)
Source: WebMD Health - May 14, 2019 Category: Consumer Health News Source Type: news

$2 Billion Verdict Against Monsanto Is Third to Find Roundup Caused Cancer
A state jury ’ s award for a Northern California couple followed awards in separate cases in March and August, and was the largest by far. (Source: NYT Health)
Source: NYT Health - May 14, 2019 Category: Consumer Health News Authors: PATRICIA COHEN Tags: Defoliants and Herbicides Bayer AG Monsanto Company California Hazardous and Toxic Substances Non-Hodgkin's Lymphoma Decisions and Verdicts Pilliod, Alberta Pilliod, Alva Source Type: news

Couple who suffered the same cancer awarded $2 billion in Roundup trial
A California jury ordered Bayer - which owns Monsanto - to pay Alva and Alberta Pilliod $2 billion in damages after ruling Roundup weedkiller was to blame for their non-Hodgkin's lymphoma. (Source: the Mail online | Health)
Source: the Mail online | Health - May 14, 2019 Category: Consumer Health News Source Type: news

Monsanto Expert: 'No Evidence Of Causal Connection' Between Roundup And Cancer
OAKLAND, Calif. - An expert for Monsanto Co. on May 1 testified that "there is no evidence of a causal association between Roundup and non-Hodgkin's lymphoma," as the glyphosate cancer trial of a California couple continued into its 18th day. The parties say that closing arguments are expected May 7 (Alva Pilliod, et al. v. Monsanto Company, No. RG17862702, Calif. Super., Alameda Co.). (Source: LexisNexis® Mealey's™ Emerging Toxic Torts Legal News)
Source: LexisNexis® Mealey's™ Emerging Toxic Torts Legal News - May 8, 2019 Category: Medical Law Source Type: news

F.D.A. Won ’t Ban Sales of Textured Breast Implants Linked to Cancer
Many other countries have already banned the products. But the U.S. agency said the risk was still low, despite repeated requests from women and doctors that the implants be removed from the market. (Source: NYT)
Source: NYT - May 6, 2019 Category: American Health Authors: Denise Grady and Roni Caryn Rabin Tags: Breasts Implants Recalls and Bans of Products Food and Drug Administration Plastic Surgery Non-Hodgkin ' s Lymphoma Allergan Inc your-feed-science your-feed-healthcare Source Type: news

N.S. man's Stage 4 cancer is in remission after $900K treatment in Boston
It's too early to know if Stephen Saunders has been cured of non-Hodgkin lymphoma, but he's in remission thanks to a treatment not yet available in Nova Scotia. (Source: CBC | Health)
Source: CBC | Health - May 3, 2019 Category: Consumer Health News Tags: News/Canada/Nova Scotia Source Type: news

EPA says glyphosate, the main ingredient in Roundup, doesn't cause cancer
The announcement comes after two high-profile court cases in which cancer patients claimed Roundup, a popular weedkiller containing glyphosate, caused their non-Hodgkin's lymphoma. Jurors awarded both patients tens of millions of dollars. (Source: CNN.com - Health)
Source: CNN.com - Health - May 1, 2019 Category: Consumer Health News Source Type: news

Science Saturday: New genetic test classifies lymphomas
The current diagnostic tools in a pathologist's arsenal sometimes cannot provide a clear distinction between primary mediastinal large B-cell lymphoma (one of the few lymphomas more common in younger women) and diffuse large B-cell lymphoma, the most common type of non-Hodgkin's lymphoma overall. This may occasionally give rise to diagnostic inaccuracy in routine practice and could leave [...] (Source: Mayo Clinic Research News)
Source: Mayo Clinic Research News - April 27, 2019 Category: Research Source Type: news

Promising Results in Mice Prompt Human Trial of Novel Lymphoma Vaccine Promising Results in Mice Prompt Human Trial of Novel Lymphoma Vaccine
An in situ vaccine (ISV) combined with immune stimulants and radiotherapy showed efficacy in mice, prompting a phase 1 trial of patients with advanced indolent non-Hodgkin's lymphoma (INHL), researchers say.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - April 24, 2019 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Couple that suffered the same cancer after using Roundup for 30 years tells heartbreaking story
Alva and Alberta Pilliod testified this week that they used Monsanto's Roundup for 30 years before they both developed non-Hodgkins lymphoma. They say the weedkiller caused it. (Source: the Mail online | Health)
Source: the Mail online | Health - April 20, 2019 Category: Consumer Health News Source Type: news

Lenalidomide Plus Rituximab Ups Response in Relapsed Indolent Lymphoma Lenalidomide Plus Rituximab Ups Response in Relapsed Indolent Lymphoma
In patients with relapsed or refractory indolent non-Hodgkin lymphoma, adding lenalidomide to rituximab improves response, according to a placebo-controlled trial.Reuters Health Information (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - April 4, 2019 Category: Allergy & Immunology Tags: Hematology-Oncology News Source Type: news

Researchers discover how tumor-killing immune cells attack lymphomas in living mice
(Rockefeller University Press) In a study that will be published April 1 in the Journal of Experimental Medicine, researchers from the Institut Pasteur and INSERM reveal that chimeric antigen receptor (CAR) T cells can induce tumor regression by directly targeting and killing cancer cells, uncovering new details of how these immune cells work and how their effectiveness could be improved in the treatment of non-Hodgkin's lymphoma and other B cell cancers. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - April 1, 2019 Category: Cancer & Oncology Source Type: news

California Man Awarded $ 80 Million in Roundup Lawsuit
Jury previously found Roundup was a significant factor in plaintiff's non - Hodgkin lymphoma (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - March 29, 2019 Category: Cancer & Oncology Tags: Oncology, Pathology, Institutional, Source Type: news

Bayer ordered to pay $81M in Roundup cancer case
A federal jury has ordered Bayer to pay $81 million to a California man who said his use of the company's Roundup weedkiller caused him to develop cancer. The ruling is the latest against Bayer involving Roundup, which was developed by St. Louis-based Monsanto before the company was acquired by Bayer last year for $62.5 billion. A San Francisco jury said Wednesday that the company is liable for the man's non-Hodgkin lymphoma, according to Reuters. Edwin Hardeman was awarded $5.9 million in compensatory… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - March 27, 2019 Category: Pharmaceuticals Authors: Vince Brennan Source Type: news

Bayer ordered to pay $81M in Roundup cancer case
A federal jury has ordered Bayer to pay $81 million to a California man who said his use of the company's Roundup weedkiller caused him to develop cancer. The ruling is the latest against Bayer involving Roundup, which was developed by St. Louis-based Monsanto before the company was acquired by Bayer last year for $62.5 billion. A San Francisco jury said Wednesday that the company is liable for the man's non-Hodgkin lymphoma, according to Reuters. Edwin Hardeman was awarded $5.9 million in compensatory… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - March 27, 2019 Category: Biotechnology Authors: Vince Brennan Source Type: news

Jury rules Monsanto IS liable for man's cancer after his years using Roundup
Edwin Hardeman of Santa Rosa, California, has non-Hodgkin's lymphoma, a cancer of the immune system, after using Roundup to kill poison oak on his 56-acre property over 30 years. (Source: the Mail online | Health)
Source: the Mail online | Health - March 27, 2019 Category: Consumer Health News Source Type: news

Bellwether Glyphosate Cancer Trial Heads To Phase 2 To Determine Liability
SAN FRANCISCO - Phase 2 of the federal bellwether glyphosate cancer trial in California started March 20, after a jury the first phase found that the chemical, which is the active ingredient in Monsanto Co.'s herbicide Roundup, was "a substantial factor" in causing the plaintiff's non-Hodgkin lymphoma (NHL) (In re: Roundup Products Liability Litigation, MDL No. 2741, N.D. Calif.). (Source: LexisNexis® Mealey's™ Emerging Toxic Torts Legal News)
Source: LexisNexis® Mealey's™ Emerging Toxic Torts Legal News - March 26, 2019 Category: Medical Law Source Type: news

Glyphosate A 'Substantial Factor' In Causing Cancer, Jury Says; Trial Continues
SAN FRANCISCO - A jury in a federal bellwether glyphosate cancer trial in California on March 19 found that the chemical, which is the active ingredient in Monsanto Co.'s herbicide Roundup, was "a substantial factor" in causing the plaintiff's non-Hodgkin lymphoma. Phase 2 of the trial, to determine liability and damages, is slated to begin March 20 (In re: Roundup Products Liability Litigation, MDL No. 2741, N.D. Calif.). (Source: LexisNexis® Mealey's™ Emerging Toxic Torts Legal News)
Source: LexisNexis® Mealey's™ Emerging Toxic Torts Legal News - March 26, 2019 Category: Medical Law Source Type: news

Study: People Exposed To Glyphosate Have Increased Risk Of Cancer
LONDON - A study published in the International Journal of Epidemiology on March 18 found that there was an elevation of risk for non-Hodgkin lymphoma (NHL) in people who were exposed to glyphosate, the active ingredient in the herbicide Roundup. (Source: LexisNexis® Mealey's™ Emerging Toxic Torts Legal News)
Source: LexisNexis® Mealey's™ Emerging Toxic Torts Legal News - March 26, 2019 Category: Medical Law Source Type: news

FDA Scrambles to Prevent Shortages Amid Sterilization Shutdowns
Shutdowns of two facilities that use ethylene oxide to sterilize medical devices have raised concern about potential shortages in the medtech industry because this is such a popular sterilization method for medical devices. Ethylene oxide (EtO) is a flammable, colorless gas used to make a range of products. EtO also is used to sterilize equipment and plastic devices that cannot be sterilized by steam, such as medical equipment. In fact, about half of all sterilized medical devices undergo sterilization using this gas. According to the EPA, long-term exposure to EtO can irritate the eyes,...
Source: MDDI - March 26, 2019 Category: Medical Devices Authors: Amanda Pedersen Tags: Sterilization Regulatory and Compliance Source Type: news

Watch where you spray: Study reveals high pesticide exposure is linked to olfactory impairment in aging farmers
(Natural News) Some of the dangers of pesticide exposure are painfully obvious – just ask the many people suffering from non-Hodgkin lymphoma after years of exposure to glyphosate. However, some negative effects are far more insidious, sneaking up on people so slowly that they don’t even make the connection to pesticide exposure. Case in point:... (Source: NaturalNews.com)
Source: NaturalNews.com - March 22, 2019 Category: Consumer Health News Source Type: news

Study: Antiretroviral therapy crucial in preventing non-Hodgkin lymphoma
A new study out of the Yale School of Public Health underscores the importance of T-cell count and viral load in developing cancer among those with HIV/AIDS. (Source: Yale Science and Health News)
Source: Yale Science and Health News - March 20, 2019 Category: Universities & Medical Training Source Type: news

Jury finds Monsanto's Roundup weed killer contributed to man's cancer
For the second time, a jury has found Monsanto's Roundup weed killer played a role in causing cancer. Tuesday's unanimous decision determined Roundup caused or was a "substantial factor" in causing 70-year-old Edwin Hardeman's non-Hodgkin's lymphoma. Anna Werner reports. (Source: Health News: CBSNews.com)
Source: Health News: CBSNews.com - March 20, 2019 Category: Consumer Health News Source Type: news

Monsanto Weedkiller Roundup Was ‘ Substantial Factor ’ in Causing Man ’ s Cancer, Jury Says
The finding was the first verdict from a federal jury in thousands of similar cases against the company. (Source: NYT Health)
Source: NYT Health - March 20, 2019 Category: Consumer Health News Authors: MIHIR ZAVERI Tags: Hardeman, Edwin Non-Hodgkin's Lymphoma Pesticides Defoliants and Herbicides Hazardous and Toxic Substances Suits and Litigation (Civil) Monsanto Company Bayer AG Source Type: news

Jury finds Monsanto's Roundup caused another man's cancer
It's the second verdict finding the active ingredient, glyphosate, led to non-Hodgkin's lymphoma in a California man (Source: Health News: CBSNews.com)
Source: Health News: CBSNews.com - March 20, 2019 Category: Consumer Health News Source Type: news

Jury finds Bayer ’s Roundup as factor in cancer case
A federal jury in San Francisco ruled Tuesday that the weedkiller Roundup, a product developed by Monsanto that was acquired by Bayer, played a significant role in a man ’s cancer.  Edwin Hardeman, a California resident, used the weedkiller in his yard, and the jury found that the exposure to Roundup caused him to develop non-Hodgkin lymphoma, according to the Wall Street Journal. Now the case moves into the next phase for jurors to decide whether the Monsanto unit of Bayer is liable, which could… (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - March 20, 2019 Category: American Health Authors: Vince Brennan Source Type: news

Jury finds Bayer ’s Roundup as factor in cancer case
A federal jury in San Francisco ruled Tuesday that the weedkiller Roundup, a product developed by Monsanto that was acquired by Bayer, played a significant role in a man ’s cancer.  Edwin Hardeman, a California resident, used the weedkiller in his yard, and the jury found that the exposure to Roundup caused him to develop non-Hodgkin lymphoma, according to the Wall Street Journal. Now the case moves into the next phase for jurors to decide whether the Monsanto unit of Bayer is liable, which could… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - March 20, 2019 Category: Biotechnology Authors: Vince Brennan Source Type: news

Jury rules Roundup was a 'substantial factor' in causing ANOTHER man's cancer
Edwin Hardeman, 70, of Santa Rosa, California, has non-Hodgkin's lymphoma, a cancer of the immune system after using the weed killer in his garden for 30 years. (Source: the Mail online | Health)
Source: the Mail online | Health - March 20, 2019 Category: Consumer Health News Source Type: news

Blogger, 22, battling cancer reveals she is in remission
Ashleigh Rimmer, of Colne in Lancashire, was told last July she had a form of blood cancer called Non-Hodgkin lymphoma. She announced her good news in her latest blog post. (Source: the Mail online | Health)
Source: the Mail online | Health - March 8, 2019 Category: Consumer Health News Source Type: news

Reproductive Factors, Hormone Use, and Risk of B-Cell NHL Reproductive Factors, Hormone Use, and Risk of B-Cell NHL
This study investigated the roles of reproductive factors and exogenous hormone use in risk of B-cell non-Hodgkin lymphoma.American Journal of Epidemiology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - February 26, 2019 Category: Consumer Health News Tags: Internal Medicine Journal Article Source Type: news

Oral Duvelisib Potential New Option for Indolent Non-Hodgkin Lymphoma
The DYNAMO study demonstrated that the oral PI3K gamma inhibitor duvelisib produced an overall response rate in patients with heavily pretreated indolent non-Hodgkin lymphoma. (Source: CancerNetwork)
Source: CancerNetwork - February 26, 2019 Category: Cancer & Oncology Authors: Leah Lawrence Source Type: news

Glyphosate exposure found to hike non-Hodgkin lymphoma risk by 41% ... and this deadly weed killer chemical inundates our food supply
(Natural News) Natural News has been warning for years that glyphosate – the primary ingredient in Roundup, the world’s most widely used weed killer – causes cancer. Though studies were published in peer-reviewed journals confirming this link, Monsanto was able to use its massive political clout and almost bottomless funds to tear these studies apart... (Source: NaturalNews.com)
Source: NaturalNews.com - February 20, 2019 Category: Consumer Health News Source Type: news

Study: Glyphosate-Based Herbicide Exposure Increases Cancer Risk By 41 Percent
BERKELEY, Calif. - A team of researchers led by a scientist at the University of California Berkeley released a study on Feb. 5 that concludes that "the overall meta-relative risk" of non-Hodgkin lymphoma (NHL) in a person exposed to glyphosate-based herbicides (GBHs) is 41 percent higher than in those who are not exposed to the chemical. (Source: LexisNexis® Mealey's™ Emerging Toxic Torts Legal News)
Source: LexisNexis® Mealey's™ Emerging Toxic Torts Legal News - February 19, 2019 Category: Medical Law Source Type: news

Common Weed Killer Glyphosate Increases Cancer Risk By 41%, Study Says
(CNN) — Glyphosate, an herbicide that remains the world’s most ubiquitous weed killer, raises the cancer risk of those exposed to it by 41%, a new analysis says. Researchers from the University of Washington evaluated existing studies into the chemical — found in weed killers including Monsanto’s popular Roundup — and concluded that it significantly increases the risk of non-Hodgkin lymphoma (NHL), a cancer of the immune system. “All of the meta-analyses conducted to date, including our own, consistently report the same key finding: exposure to GBHs (glyphosate-based herbicides) are asso...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - February 15, 2019 Category: Consumer Health News Authors: Health – CBS Boston Tags: Health News CNN weed killer Source Type: news